Abstract 3369: Intravenous Autologous Bone Marrow Derived Stem Cell Therapy for Patients with Subacute Ischemic Stroke (InVeST): A Multi-Centric Randomized Controlled Trial

Abstract only Background & Objective We have completed a randomized controlled clinical trial (CTRI-PROVCTRI/2008/091/00046) to evaluate the safety and efficacy of administering bone marrow mononuclear cells intravenously to patients with subacute ischemic stroke. Methods A total 120 consecutive...

Full description

Saved in:
Bibliographic Details
Published in:Stroke (1970) 2012-02, Vol.43 (suppl_1)
Main Authors: Prasad, Kameshwar, Johari, S., Gorthi, S. P, Sarkar, R. S, Prabhakar, Sudesh, Mishra, U K, Bhatnagar, Shinjini
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract only Background & Objective We have completed a randomized controlled clinical trial (CTRI-PROVCTRI/2008/091/00046) to evaluate the safety and efficacy of administering bone marrow mononuclear cells intravenously to patients with subacute ischemic stroke. Methods A total 120 consecutive, eligible and consenting patients, aged 18 to 75 years with ischemic stroke involving MCA or ACA territory infarct between 7 to
ISSN:0039-2499
1524-4628
DOI:10.1161/str.43.suppl_1.A3369